OAK HILL BIO HOLDINGS LTD
Company number 13746073 · Monitor this company
Free AI analysis
Have an AI read this company's filings and write an assessment — financial health, risks, and what the numbers say.
Overview
- Company type
- Private Limited Company
- Incorporated
- 2021-11-16
- Registered office
- 3rd Floor 1 Ashley Road, Altrincham, Cheshire, United Kingdom, WA14 2DT
- Postcode
- WA14 2DT
- Capital
- 29 GBP
- Accounts category
- Group
Accounts
- Last made up to
- 2024-12-31
- Next due by
- 2026-09-30
- Financial year end
- 31 December
Confirmation statement
- Last statement dated
- 2025-10-31
- Next due by
- 2026-11-14
Nature of business (SIC)
- 72110 Research and experimental development on biotechnology
Officers 7 current · 9 resigned
Parvinder THIARA
Director
Mohammad Hussein, Dr. AL-MOSSAWI
Director
Kim DAVIS
Director
David COLPMAN
Director
OAKWOOD CORPORATE SECRETARY LIMITED
Corporate Secretary
Group structure 3 subsidiaries
From persons-with-significant-control filings on the public register.
Contact details
- Website
- oakhillbio.com
- Phone
- +44 1865 966499
Oak Hill Bio is a clinical-stage biotechnology company focused on acquiring and developing outstanding rare disease drugs that have been deprioritized by big pharma. The company's lead program is rugonersen (OHB-724), an investigational oligonucleotide entering Phase 3 that has best-in-class potential as a treatment for Angelman syndrome, a devastating neurodevelopmental disorder with no approved disease-modifying therapies.
Previous company names
| Name | Date changed |
|---|---|
| OAK HILL BIO LTD | 2026-06-18 |